Statistics for Treatment Outcome of FOLFOX Versus Carboplatin–Paclitaxel as First Line Therapy for Advanced Squamous Cell Carcinoma of the Esophagus At TASH, Addis Ababa Ethiopia: A Comparative Retrospective Study.
Total visits
| views | |
|---|---|
| Treatment Outcome of FOLFOX Versus Carboplatin–Paclitaxel as First Line Therapy for Advanced Squamous Cell Carcinoma of the Esophagus At TASH, Addis Ababa Ethiopia: A Comparative Retrospective Study. | 6 |
Total visits per month
| views | |
|---|---|
| March 2026 | 0 |
| April 2026 | 0 |
| May 2026 | 0 |
| June 2026 | 0 |
| July 2026 | 0 |
| August 2026 | 4 |
| September 2026 | 2 |
File Visits
| views | |
|---|---|
| Ikram_Musa_2025_EDT.pdf.pdf | 9 |